Ad is loading...
MENU
VKTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Viking Therapeutics (VKTX) Earnings Date & Reports

Industry: @Biotechnology
A.I. Advisor
published Earnings

VKTX is expected to report earnings to rise 28.59% to -28 cents per share on February 05

Viking Therapeutics VKTX Stock Earnings Reports
Q4'24
Est.
$-0.28
Q3'24
Beat
by $0.02
Q2'24
Beat
by $0.06
Q1'24
Beat
by $0.02
Q4'23
Beat
by $0.01
The last earnings report on October 23 showed earnings per share of -21 cents, beating the estimate of -23 cents. With 8.14M shares outstanding, the current market capitalization sits at 5.53B.
View a ticker or compare two or three
VKTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a company that engages in the development of therapies for metabolic and endocrine disorders

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
9920 Pacific Heights Boulevard
Phone
+1 858 704-4660
Employees
27
Web
https://www.vikingtherapeutics.com